Your browser doesn't support javascript.
loading
Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study.
Moriya, Kei; Asada, Kiyoshi; Suzuki, Shota; Enomoto, Masahide; Fujinaga, Yukihisa; Tsuji, Yuki; Namisaki, Tadashi; Yoshiji, Hitoshi.
Afiliação
  • Moriya K; Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, Nara, Japan.
  • Asada K; Institute for Clinical and Translational Science, Nara Medical University, Kashihara, Nara, Japan.
  • Suzuki S; Institute for Clinical and Translational Science, Nara Medical University, Kashihara, Nara, Japan.
  • Enomoto M; Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, Nara, Japan.
  • Fujinaga Y; Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, Nara, Japan.
  • Tsuji Y; Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, Nara, Japan.
  • Namisaki T; Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, Nara, Japan.
  • Yoshiji H; Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, Nara, Japan.
Medicine (Baltimore) ; 101(48): e32127, 2022 Dec 02.
Article em En | MEDLINE | ID: mdl-36482520
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hesperidina / Cirrose Hepática Biliar Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hesperidina / Cirrose Hepática Biliar Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article